ARVO Disclosure Guidelines Presenting Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject.

Slides:

Advertisements

Similar presentations

VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.

Advertisements

Financial Conflict of Interest July 2012 rev

Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.

Managing Conflicts of Interest © ACCME.

Reviewer Disclosure Guide 1) Ensure disclosed information is complete Reviewer Responsibilities 2) Assign a conflict of interest category 3) Develop management.

3 rd Party Entity A. Individual Financial Interests B. Spouse Financial Interests C. Dep. Children Financial Interests D. Collective (A+B+C) E. Significant.

YOUR DISCLOSURE STATEMENT Of particular note this year is a rule change by ACCME regarding standards for commercial support, specifically: Standard 4.3:

Sample Disclosure Slides Information: A presenter must include Disclosure slides for each presentation – even if nothing to disclose Two slides are required.

Japan Society for Hematopoietic Cell Transplantation COI disclosure Name of first author ： e.g., John Doe I have no personal or financial interests to.

Disclose to APM and meeting attendees the existence of any financial relationships with any for-profit companies that are directly or indirectly related.

[Session Number: Title] [Speaker Optional: Job title Institution]

Title text here in Arial or Helvetica Bold 40 Adjust font size as needed. Presentation (Program) Number (Number provided in the body of your Abstract Scheduling.

Financial Interest Disclosure (over the past 24 months) Commercial Interest Relationship Company A advisory board, consultant, investigator Company B speaker.

Speaker Name: Disclosure of Relevant Financial Relationships

YOUR DISCLOSURE STATEMENT

Insert Abstract Title Text Here in Calibri, Arial, or Helvetica

We have no conflict of interests related to

Per SROA Policy, Workshop Speakers are Expected to:

Conflict of Interest Disclosure

Conflict of Interest Disclosure

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

2018 Canadian Transplant Summit - DISCLOSURE FORM

Relevant Financial Disclosure(s)

Japanese Society of Allergology COI Disclosure Name of lead presenter

Speaker Disclosure slides for presentations

Financial Interests or Relationships

Conflict of Interest Disclosure:

Faculty Disclosure In accordance with the policy of the Cardiac Society of Australia and New Zealand the following presenter has indicated that they have.

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

TOPIC 2018 COI Disclosure Name of Author :

Conflict of Interest Disclosure (over the past 24 months)

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Disclosure of conflicts of interest – explanation

様式１AB （Form4－Ａ）　If there is no state of conflict of interest requiring disclosure The Japanese Society of Neurology (JSN) ＣＯＩ Disclosure 　 Name of Lead.

Conflict of Interest Disclosure

COI Disclosure All authors Name : （◎ Corresponding author）

Conflict of interest disclosure

Financial Interests or Relationships

Disclosures The project was funded from the following sources:

Financial Disclosure Financial Interest / Affiliation

様式１AB （Form4－Ａ）　If there is no state of conflict of interest requiring disclosure The Japanese Society of Neurology (JSN) ＣＯＩ Disclosure 　 Name of Lead.

Disclosures Relevant financial relationships in the past twelve months by presenter or spouse/partner. Employment: Company Name(s) Speakers Bureau:

Conflict of Interest Disclosure

Title of Talk Speaker name.

Use the following slide to disclose any conflicts of interest

様式１AB （Form4－Ａ）　If there is no state of conflict of interest requiring disclosure The Japanese Society of Neurology (JSN) ＣＯＩ Disclosure 　 Name of Lead.

Disclosure Guidelines

Disclosure Guidelines

Disclosure of conflicts of interest

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

We have no conflict of interests related to

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

Presentation (Program) Number

COI Disclosure Name of Author： Gildong Hong

Disclosure of conflicts of interest

We have no conflict of interests related to

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

COI Disclosure All authors Name : （◎ Corresponding author）

Financial and Other Disclosures

Financial Disclosure Financial Interest / Affiliation

< Title > < Sub-title >

Declaration of Financial Interests or Relationships

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

Please include this slide if you answered “yes” to at least one of the questions.

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

ARVO Disclosure Guidelines

Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Company Employment full time / part.

様式１AB （Form4－Ａ）　If there is no state of conflict of interest requiring disclosure The Japanese Society of Neurology (JSN) ＣＯＩ Disclosure 　 Name of Lead.

様式１AB （Ｆｏｒｍ　4－C）　Disclosure of the state of conflict of interest at the end of a poster at a poster session Lead presenter: There are no companies, etc.

COI Disclosure For speakers with a COI to declare

Presentation transcript:

ARVO Disclosure Guidelines Presenting Authors must fully disclose to ARVO and the session participants all commercial relationships relevant to the subject matter for all authors of the presentation and their spouse or partner for the prior 24 months. All full disclosures must be indicated orally and on a slide at the beginning of the presentation. A full disclosure will include the name(s) of the commercial interest and the nature of the relationship(s). Indicate “None” if no relationships exist. View the ARVO Commercial Relationships Policy for complete reporting requirements.ARVO Commercial Relationships Policy

ARVO Disclosure Codes Definitions F (Financial Support) Indicates financial support received from an ACCME-defined commercial interest, in the form of research funding, grants, research materials or in-kind services (e.g., protein sequencing). I (Personal Financial Interest) Indicates you are an investor in a company or competing company, including an ACCME-defined commercial interest, other than through a mutual or retirement fund. E (Employment) Indicates you are an employee of an ACCME-defined commercial interest. C (Consultant) Indicates you are a consultant for an ACCME-defined commercial interest. P (Patent) Indicates you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether or not the patent, copyright, etc. is presently licensed or otherwise commercialized, or could be in competition with the technology described. R (Recipient) Indicates you have received gifts, honoraria, travel reimbursement, patent royalties, or any other financial compensation valued in any amount from an ACCME-defined commercial interest. N (No Commercial Relationship) Indicates there is no commercial relationship relevant to the subject matter of the abstract/article/presentation. S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc.

Disclosure Example 1 F (Financial Support): Acme Company (research funding) I (Personal Financial Interest): Cyberdyne Systems Corp. (shareholder) C (Consultant): Stark Industries, Tyrell Corp, Wayne Enterprises (consultant) P (Patent): Cyberdyne Systems Corp. (licensed patents related to cybernetic prostheses) R (Recipient): Cyberdyne Systems Corp. (dividends and royalties) S: Globex, Oscorp, Virtucon (non-remunerated board member)

Disclosure Example 2 Acme Company (F), Cyberdyne Systems Corp. (I, P, R), Globex (S), Oscorp (S), Stark Industries (C), Tyrell Corp (C), Virtucon (S), Wayne Enterprises (C)

Disclosure Example 3 N: No commercial relationships relevant to the subject matter of the presentation

Disclosure Example 4 Commercial Relationships: None